See more : Battery Future Acquisition Corp. WT (BFAC-WT) Income Statement Analysis – Financial Results
Complete financial analysis of OrganiGram Holdings Inc. (OGI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of OrganiGram Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS) Income Statement Analysis – Financial Results
- Hologic, Inc. (0J5Q.L) Income Statement Analysis – Financial Results
- PT Bank of India Indonesia Tbk (BSWD.JK) Income Statement Analysis – Financial Results
- NIHON CHOUZAI Co.,Ltd. (3341.T) Income Statement Analysis – Financial Results
- Compañía de Distribución Integral Logista Holdings, S.A. (LOG.MC) Income Statement Analysis – Financial Results
OrganiGram Holdings Inc. (OGI)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.organigram.ca
About OrganiGram Holdings Inc.
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 159.84M | 149.21M | 145.81M | 79.16M | 86.80M | 80.41M | 12.43M | 5.71M | 6.13M | 986.68K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 112.32M | 114.13M | 114.24M | 107.56M | 143.29M | 31.94M | 39.20M | 8.84M | 813.38K | 339.51K | 274.91K | 0.00 | 0.00 |
| Gross Profit | 47.52M | 35.07M | 31.57M | -28.40M | -56.49M | 48.47M | -26.78M | -3.13M | 5.31M | 647.17K | -274.91K | 0.00 | 0.00 |
| Gross Profit Ratio | 29.73% | 23.51% | 21.65% | -35.87% | -65.08% | 60.28% | -215.42% | -54.73% | 86.73% | 65.59% | 0.00% | 0.00% | 0.00% |
| Research & Development | 11.20M | 12.19M | 5.96M | 3.45M | 1.27M | 409.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 48.29M | 48.95M | 42.35M | 30.72M | 29.94M | 26.67M | 9.27M | 4.78M | 2.31M | 1.76M | 66.77K | 318.91K | 140.16K |
| Selling & Marketing | 19.85M | 17.86M | 16.86M | 15.81M | 16.53M | 14.63M | 6.30M | 2.85M | 1.76M | 720.97K | 181.44K | 0.00 | 0.00 |
| SG&A | 68.14M | 71.68M | 59.21M | 46.52M | 46.47M | 41.30M | 15.57M | 7.62M | 4.07M | 2.49M | 66.77K | 318.91K | 140.16K |
| Other Expenses | 3.85M | 0.00 | 5.15M | -5.53M | -6.37M | 664.00K | 509.00K | 416.36K | 0.00 | 0.00 | 0.00 | 56.33K | 0.00 |
| Operating Expenses | 83.20M | 271.48M | 70.32M | 44.44M | 41.37M | 42.37M | 16.08M | 8.04M | 4.07M | 2.49M | 66.77K | 375.25K | 140.16K |
| Cost & Expenses | 195.51M | 385.61M | 184.56M | 152.00M | 184.65M | 74.31M | -23.99M | 16.88M | 4.88M | 2.15M | 66.77K | 375.25K | 140.16K |
| Interest Income | 0.00 | 3.69M | 1.49M | 854.00K | 308.00K | 662.00K | 0.00 | 9.87K | 0.00 | 0.00 | 996.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 277.85K | 429.00K | 2.96M | 6.01M | 9.67M | 10.09M | 273.87K | 436.37K | 115.41K | 996.00 | 0.00 | -140.16K |
| Depreciation & Amortization | 12.08M | 23.42M | 24.91M | 31.03M | 17.96M | 8.90M | 3.53M | 1.56M | 785.59K | 414.80K | 173.53K | 0.00 | 0.00 |
| EBITDA | -23.59M | -25.37M | -15.21M | -42.92M | -122.66M | 12.70M | 41.40M | -9.62M | 2.03M | -746.65K | 106.76K | -375.25K | -140.16K |
| EBITDA Ratio | -14.76% | -17.00% | -10.43% | -54.22% | -93.42% | 17.09% | 321.38% | -168.30% | 33.15% | -75.42% | 0.00% | 0.00% | 0.00% |
| Operating Income | -35.67M | -48.79M | -38.75M | -91.82M | -145.51M | 5.49M | 36.42M | -11.17M | 1.25M | -1.16M | -66.77K | -375.25K | -140.16K |
| Operating Income Ratio | -22.32% | -32.70% | -26.58% | -115.99% | -167.65% | 6.82% | 292.99% | -195.44% | 20.33% | -117.46% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -9.77M | -184.21M | 24.38M | -38.88M | -46.98M | -11.36M | -8.64M | 211.32K | -398.97K | -117.90K | 1.38M | 0.00 | 0.00 |
| Income Before Tax | -45.44M | -233.00M | -14.37M | -130.70M | -146.63M | -5.88M | 27.78M | -10.89M | 846.66K | -1.28M | -239.31K | -375.25K | 0.00 |
| Income Before Tax Ratio | -28.43% | -156.16% | -9.86% | -165.11% | -168.94% | -7.31% | 223.49% | -190.59% | 13.82% | -129.41% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 3.52M | -88.00K | 1.84M | -10.47M | 3.63M | 5.65M | -550.94K | -37.41K | 2.49K | 171.54K | 0.00 | 140.16K |
| Net Income | -45.44M | -229.48M | -14.28M | -132.55M | -136.16M | -9.50M | 20.51M | -10.89M | 846.66K | -1.28M | -239.31K | -375.25K | -140.16K |
| Net Income Ratio | -28.43% | -153.80% | -9.80% | -167.43% | -156.87% | -11.82% | 165.04% | -190.59% | 13.82% | -129.41% | 0.00% | 0.00% | 0.00% |
| EPS | -0.44 | -2.82 | -0.18 | -2.07 | -3.15 | -0.27 | 0.68 | -0.45 | 0.06 | -0.10 | -0.12 | -0.18 | -0.08 |
| EPS Diluted | -0.42 | -2.82 | -0.18 | -2.07 | -3.15 | -0.27 | 0.65 | -0.45 | 0.06 | -0.10 | -0.12 | -0.18 | -0.08 |
| Weighted Avg Shares Out | 103.80M | 81.29M | 77.23M | 64.03M | 43.17M | 35.23M | 30.14M | 24.30M | 14.67M | 13.10M | 2.07M | 2.07M | 1.75M |
| Weighted Avg Shares Out (Dil) | 108.38M | 81.29M | 77.23M | 64.03M | 43.17M | 35.23M | 31.72M | 24.30M | 14.67M | 13.10M | 2.07M | 2.07M | 1.75M |
Are Medical Stocks Lagging OrganiGram (OGI) This Year?
Here is how OrganiGram (OGI) and ResMed (RMD) have performed compared to their sector so far this year.
Organigram Is My Favorite Cannabis Stock Again
Organigram stock has performed well this year, despite an equity raise and a temporary pullback caused by Tilray's poor financial report. The fiscal Q1 report showed a revenue shortfall, particularly in international sales, but positive operating cash flow. Analysts' outlook...
Organigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, celebrates a monumental achievement as its SHRED brand surpasses the $200 million mark in yearly retail sales.1 SHRED revolutionized the cannabis industry...
Everything Golden for Nexsan on Eve of Silver Anniversary
SUNNYVALE, Calif.--(BUSINESS WIRE)--Nexsan®, the pioneer of highly reliable, cost-effective enterprise-class storage solutions, is celebrating 25 years of delivering storage solutions enterprises trust for their most critical data needs, backed by the innovation and reliability that has made the company a...
Organigram Successfully Closes Previously Announced Underwritten Public Offering
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI) announces today the closing of its previously announced underwritten public offering of units of the Company (the “Units”) for total gross proceeds of C$28,750,230 (the “Offering”). The Company...
Why OrganiGram (OGI) Might Surprise This Earnings Season
OrganiGram (OGI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Organigram Announces Pricing of Overnight Marketed Public Offering
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today that, in connection with its previously announced overnight marketed public offering of units of the Company (the “Units”), it has entered into an underwriting agreement with...
Organigram Announces Launch of Overnight Marketed Public Offering
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today an overnight marketed public offering of units of the Company (the “Units”) for total gross proceeds of approximately C$25 million (the “Offering”). The Offering is expected...
Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) is pleased to announce a US $2 million minority investment in Steady State LLC (d/b/a Open Book Extracts) (“OBX”) in the form of a convertible note. Based in...
The Marijuana Stocks Could See A Rise This Week
People who have been investing in marijuana stocks could soon a big change. Now this change is more from an industry standpoint which can in turn help how marijuana stocks trade. As most publicly traded companies news about the sector...
Source: https://incomestatements.info
Category: Stock Reports